Sign In
Free Newsletter
Neuralstem completes sale of stock
Neuralstem Inc., of Rockville, which develops products to treat central nervous system disorders with patented stem cell technology, announced the closing of a $20 million registered direct placement of approximately 6.87 million shares of common stock at a price of $2.91 per share.
Neuralstem to conduct stock offering
Neuralstem Inc. said it will sell more than 6.75 million shares of common stock, priced at $2.91 per share, to certain institutional investors in a registered direct placement, with anticipated gross proceeds of approximately $19.65 million.
Improving U.S. economy leads Fed to ease stimulus
WASHINGTON — The Federal Reserve on Wednesday sent its strongest signal of confidence in the U.S. economy since the Great Recession, deciding that the nation’s economic prospects are finally bright enough to withstand a slight pullback in stimulus spending. Yet the Fed also made clear that it will keep supporting an economy that remains less […]
Government sells remaining stake in GM
DETROIT — The U.S. government ended up losing $10.5 billion on the General Motors bailout, but it says the alternative would have been far worse. The Treasury Department sold its final shares of the Detroit auto giant on Monday, recovering $39 billion of the $49.5 billion it spent to save the dying automaker at the […]
Twitter surges in opening trade on NYSE
NEW YORK — Shares of Twitter went on sale to the public for the first time Thursday, instantly leaping more than 70 percent above their offering price in a dazzling debut that exceeded even Wall Street’s lofty hopes for the most anticipated initial public offering since Facebook last year. At the opening bell, the social […]
Poll: Twitter faces skeptical investors
NEW YORK — Twitter faces skepticism from potential investors and the broader public ahead of its initial public offering, according to an Associated Press-CNBC poll released Monday. Some 36 percent of Americans say buying stock in the 7-year-old short messaging service would be a good investment, while 47 percent disagree. Last May, ahead of Facebook’s […]
Wall Street puts its focus back on earnings, not D.C.
NEW YORK — The stock market hit an all-time high Thursday as investors put the government shutdown and debt ceiling crisis behind them and focused on corporate earnings. The Standard & Poor’s 500 index rose 11.61 points, or 0.7 percent, to close at 1,733.15 — a record close. The market rose throughout the day as […]
Stocks lower on weak corporate earnings
NEW YORK — The stock market fell in early trading Thursday, dragged down by disappointing earnings from IBM and other major U.S. companies. The weak corporate results were more than enough to offset the positive news that Congress raised the nation’s borrowing limit late Wednesday to temporarily avert the United States from defaulting on its […]
Microsoft board boosts dividend by 22 pct
REDMOND, Wash. — Microsoft said Tuesday that its board approved a 22 percent increase in the company’s quarterly dividend to 28 cents along with a new $40 billion stock buyback program. The new dividend represents an increase of 5 cents over the world’s largest software company’s previous dividend. It will be paid on Dec. 12 […]
Safeway adopts poison pill after big stock buys
NEW YORK — Safeway adopted a plan to prevent a hostile takeover after learning of a significant accumulation of its stock by an unknown investor. The announcement Tuesday sent shares of the grocer spiking 8 percent to a five-year high. So-called “poison pill” plans allow existing shareholders to acquire more stock at a discounted rate […]
Dow average adds Goldman Sachs, Nike and Visa
The Dow Jones industrial average is dropping Bank of America, Hewlett-Packard and Alcoa, its three-lowest priced stocks, as part of a six-company shakeup of the most widely known barometer of the U.S. stock market. S&P Dow Jones Indices said Tuesday it will add Visa Inc., sneaker maker Nike Inc. and the investment bank Goldman Sachs […]
First woman member of the NYSE Siebert dies at 80
NEW YORK — Muriel “Mickie” Siebert, who started as a trainee on Wall Street and became the first woman to own a seat on the New York Stock Exchange, has died of complications of cancer at age 80. Siebert died Saturday at Memorial Sloan-Kettering Cancer Center in New York. Her death was confirmed by Jane […]
